Successful Treatment of Ulcerative Colitis With Vedolizumab in a Patient With an Infliximab-Associated Psoriasiform Rash

Psoriatic skin lesions associated with anti-tumor necrosis factor (TNF) agents are well-described in the medical literature. However, the etiology and optimal management of this condition remain unclear. Vedolizumab is a novel, gut-specific, anti-integrin agent used for the treatment of inflammatory...

Descripción completa

Detalles Bibliográficos
Autores principales: Hirsch, Ayal, Colman, Ruben J., Lang, Gabriel D., Rubin, David T.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American College of Gastroenterology 2015
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4508952/
https://www.ncbi.nlm.nih.gov/pubmed/26203450
http://dx.doi.org/10.14309/crj.2015.70

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4508952/
https://www.ncbi.nlm.nih.gov/pubmed/26203450
http://dx.doi.org/10.14309/crj.2015.70

Ejemplares similares